Recent findings document not only a role for syndecan-4 in lymphangiogenesis, but also in classical VEGFA-mediated angiogenesis: Syndecan-4-deficient mice show reduced angiogenesis not only in a model of diabetic retinopathy, but also in a melanoma model of tumor angiogenesis. This evidence concerns the gene SDC4 and diabetic retinopathy.